Freenome Announces Exclusive Agreement With Roche To Expand Technology Collaboration, Develop And Commercialize Cancer Screening Tests Outside U.S.
Reuters
Nov 18, 2025
Roche Holding AG :: *FREENOME: ANNOUNCES EXCLUSIVE AGREEMENT WITH ROCHE TO EXPAND TECHNOLOGY COLLABORATION, DEVELOP AND COMMERCIALIZE CANCER SCREENING TESTS OUTSIDE U.S. *FREENOME: RETAINS RIGHTS TO EX-U.S. CENTRALIZED TESTING AS WELL AS ALL U.S. RIGHTS, SUBJECT TO ITS PRE-EXISTING LICENSE TO EXACT SCIENCES *FREENOME: POTENTIALLY $200+ MILLION AGREEMENT INCLUDES $75 MILLION EQUITY INSTRUMENT, MILESTONE PAYMENTS & ROYALTIES ON EX-U.S. TEST SALES
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.